Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Dentsply sirona inc | History Defined

3 Dental Stocks That Will Keep You Smiling in 2022

The rebound in demand for dental care services and products with the easing of COVID-19 fears and adoption of advanced technologies in dental care bode well for the dental industry. Therefore, we think the stocks of quality dental companies Dentsply Sirona (XRAY), Patterson Companies (PDCO), and Henry Schein (HSIC) could…

StockNews.com · Jun 3, 2022

Why Did Moderna CFO Exit Just A Day After Taking Charge

Why Did Moderna CFO Exit Just A Day After Taking Charge

Moderna Inc (NASDAQ:MRNA) announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the company, effective immediately. The announcement follows the public disclosure by Gomez's former employer, Dentsply Sirona Inc (NASDAQ:XRAY), of an ongoing internal investigation into some issues, including financial reporting. The audit investigates Dentsply Sirona's "use of incentives to sell products to…

Benzinga · May 11, 2022

Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance

Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance

Dentsply Sirona Inc's (NASDAQ:XRAY) Q1 FY22 sales decreased 6.1% Y/Y to $965 million, missing the consensus of $988.43 billion. Adjusted EPS decreased to $0.52 from $0.72 a year ago and missed the consensus of $0.56. "The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact…

Benzinga · May 10, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Read Why HC Wainwright Cut Price Target For Dentsply Sirona

HC Wainwright has cut the price target for Dentsply Sirona Inc (NASDAQ:XRAY) from $58 to $48 (17% upside), reiterating the Neutral rating. The analysts have adjusted 2022 projections to reflect lower than expected Q1 FY22 earnings. Management noted that the results reflect weaker sales performance in the U.S., global supply chain challenges, and foreign exchange headwinds.…

Benzinga · Apr 22, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

Benzinga · Apr 20, 2022

Why Are Dentsply Sirona Shares Plummeting Today?

Dentsply Sirona Inc (NASDAQ:XRAY) appointed John Groetelaars, who serves on Dentsply Sirona's Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO, and will cease to serve as a member of the Company's Board, effective immediately. The Board has initiated a search to identify…

Benzinga · Apr 19, 2022

Dentsply Sirona's Q4 Falls Short Of Expectations, FY22 Sales Outlook Lags Street View

Dentsply Sirona Inc's (NASDAQ: XRAY)

Benzinga · Feb 28, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

1

Coverage From

Organisations

Palantir Technologies

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

420,370 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play